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a r t i c l e s
Hypertension is a complex trait, influenced by multiple genetic and environmental factors 1 . Although it has been estimated that approximately 30-50% of blood pressure variance is due to inherited genes, the molecular basis of this disease remains largely to be defined 2 . In mammals, behavior, physiology and metabolism are subject to a well-controlled daily rhythm, generated by an internal self-sustained molecular oscillator referred to as the circadian clock [3] [4] [5] [6] [7] . Because up to 10% of the transcriptome has been estimated to be under the control of the circadian clock 8 , it may not come as a surprise that malfunction of this time keeper can result in the onset of a variety of pathological events 9, 10 . Indeed, epidemiological studies show that shift workers, long-distance transmeridian flight crews and individuals with sleep disorders show a higher than average prevalence of cardiovascular diseases [11] [12] [13] . Thus, it has been speculated that impediment of the circadian clock may underlie altered cardiovascular homeostasis. However, the molecular mechanisms by which circadian clock malfunction contribute to cardiovascular disease, including hypertension, are poorly understood.
Cry-null mice lack a functional circadian clock and accordingly show arrhythmic behavior, physiology and metabolism [14] [15] [16] . Cry proteins act as potent transcriptional repressors that downregulate transcription of E-box (CACGTG) enhancer-containing clock genes (including the Period-and Cryptochrome-encoding genes), as well as a wide variety of clock-controlled genes (including the gene encoding the circadian transactivator Dbp) [16] [17] [18] . Time of day-dependent activation and repression of such E-box-containing genes are central features of normal circadian clock function. In Cry-null mice, the expression of E-box-containing genes is constitutively increased (derepressed) as a result of impaired circadian repression 16, 19, 20 .
To date, little is known about the pathological states of Cry-null mice. We and others have focused on the adrenal gland in investigating how the circadian clock system affects metabolism 21, 22 . In characterizing the endocrinological status of Cry-deficiency mice, we found abnormally high levels of aldosterone, a steroid hormone that is secreted by the adrenal glands. Aldosterone acts as a potent mineralocorticoid that promotes sodium and water retention by the kidney, thereby increasing vascular fluid volume and blood pressure 23, 24 . The plasma aldosterone concentration (PAC) is finely controlled by the renin-angiotensin-aldosterone system (RAAS), which regulates cardiovascular function and blood pressure homeostasis 2 . Because abnormal elevation of PAC has been linked to the pathogenesis of human hypertension [23] [24] [25] , our observation of increased PAC in Cry-null mice prompted us to investigate how the circadian clock might be linked to the etiology of aldosterone-dependent disorders.
Here we show that Cry-null mice have salt-sensitive hypertension due to the abnormal production of aldosterone by the adrenal glands. An extensive search for a steroidogenic enzyme that causes the adrenal dysfunction in Cry-null mice led us to identify Hsd3b6 as a key Salt-sensitive hypertension in circadian clock-deficient Cry-null mice involves dysregulated adrenal Hsd3b6 a r t i c l e s enzyme through which Cry gene inactivation results in an abnormally high PAC and salt-sensitive hypertension. Furthermore, we show that the human HSD3B1 gene is a functional counterpart to the mouse Hsd3b6 gene, as HSD3B1 is expressed in aldosterone-producing cells in the human adrenal gland.
RESULTS

Chronic hyperproduction of aldosterone by Cry-null adrenal glands
After our initial observation of increased PAC in Cry-null mice, we quantified PAC and plasma renin activity (PRA) in wild-type (WT) and mutant mice kept in constant darkness and sampled at selected circadian time points (Fig. 1) . Cry-null mice showed abnormally high PAC throughout the day (Fig. 1a) . In line with previous reports in rodents 26 , WT mice showed a mild circadian fluctuation in PAC (Fig. 1a) with overall values lower than those in Cry-null mice. The elevated PAC in Cry-null mice was not a secondary result of enhanced PRA, as PRA was markedly suppressed in Cry-null mice at both CT0 and CT12 (defined as the beginning of the subjective day and night, respectively) (Fig. 1b) . The decreased PRA in Cry-null mice is most likely due to RAAS-dependent feedback inhibition resulting from the elevated PAC 23, 24 .
The increased PAC despite a marked reduction of PRA suggested that the functioning of the adrenal gland in Cry-null mice might be affected. To assess the functionality of the Cry-null adrenal gland, we used an ex vivo tissue culture system that allowed us to evaluate the rate of aldosterone production by measuring the amount of aldosterone secreted into the culture medium. We found that the aldosterone production rate of the Cry-null adrenal gland was significantly higher than that of the WT adrenal gland (Fig. 1c) . This increased aldosterone production was observed in both adrenal glands of a Cry-null mouse (Supplementary Fig. 1 ). Taken together, these data provide evidence that Cry-null mice have a profoundly increased PAC as a result of enhanced aldosterone secretion by the adrenal gland.
Chronic hyperexpression of Hsd3b6 in Cry-null adrenal glands
To dissect the altered steroidogenesis in Cry-null mice at the molecular level, we used microarrays to survey all known mouse steroidogenic genes for their expression in the adrenal gland (Fig. 2a) . This survey identified a gene probe (1460232_s_at) for which signal intensities in the Cry-null adrenal gland were markedly increased throughout the day as compared to the WT gland. This gene probe potentially hybridizes with the Hsd3b2, Hsd3b3 and Hsd3b6 mRNA isoforms of the Hsd3b gene family. These isoforms are known to encode dehydrogenase-isomerases that catalyze the conversion of ∆ 5 -3β-hydroxysteroids into hormonally active ∆ 4 -3-ketosteroids 27 , an enzymatic reaction required for aldosterone biosynthesis 28 .
To identify all Hsd3b isoforms expressed in the mouse adrenal gland, we used an RT-PCR-based assay in combination with restriction endonuclease-mapping analysis (Supplementary Methods). We subjected adrenal total RNA to RT-PCR with a primer set capable of amplifying all classes of mouse Hsd3b genes (types I to VI). We then analyzed the identity of the PCR products by digestion of the DNA with subtypespecific restriction endonucleases (Supplementary Table 1 ). We observed that mouse adrenal glands express only type I and VI Hsd3b isoforms; the other isoforms (types II to V) were undetectable ( Supplementary  Fig. 2 ). Quantitative RT-PCR (qRT-PCR) analysis with gene-specific primers further showed that the Hsd3b gene aberrantly expressed in Cry-null adrenal glands was Hsd3b6 rather than Hsd3b1; that Hsd3b6 mRNA levels in Cry-null adrenal glands were constitutively increased compared to those in WT adrenal glands across circadian time; and that Hsd3b6 expression in WT adrenal glands, although at relatively low levels, was subject to circadian fluctuation (Fig. 2b) . In vitro promoter analysis (Supplementary Fig. 3a ) revealed that the transcription of Hsd3b6 is positively controlled by Dbp, suggesting that the enhanced Dbp expression in Cry-null mice (refs. 17 and 20 and Supplementary Fig. 3b ) could account for the hyperexpression of Hsd3b6 in Cry-null adrenal glands ( Supplementary Fig. 3c,d ).
Hsd3b6 is exclusively expressed in zona glomerulosa cells
In situ hybridization analysis with a radiolabeled Hsd3b6 probe (Fig. 2c) not only confirmed the marked elevation of Hsd3b6 mRNA in Cry-null adrenal glands but also uncovered a unique spatial arrangement of Hsd3b6 expression. This analysis showed that Hsd3b6 is expressed almost exclusively in the outer layer of the adrenal cortex ( Fig. 2c and Supplementary Fig. 4) . Analysis of Hsd3b6 expression by emulsion autoradiography (data not shown) and digoxigenin in situ hybridization ( Supplementary Fig. 5a ) further illustrated that the Hsd3b6-positive cells were localized in the outermost cortical layer, termed the zona glomerulosa.
The predominant expression of Hsd3b6 in the zona glomerulosa is particularly noteworthy because the production of aldosterone is known to take place exclusively in this region 29 . The zona glomerulosa is functionally characterized by the expression of the Cyp11b2 gene, which encodes the aldosterone synthase required for the final step of aldosterone synthesis 30, 31 . Notably, our in situ hybridization analysis suggested that Hsd3b6 and Cyp11b2 are both expressed mainly in adrenal zona glomerulosa cells ( Fig. 2c and Supplementary Fig. 5b ). In marked contrast to the local expression of Hsd3b6, Hsd3b1 was expressed more broadly in the adrenal cortex (Fig. 2c) , similar to WT, n = 6, Cry-null, n = 6; CT12: WT, n = 12, Cry-null, n = 10). Shown are the amounts of aldosterone secreted into serum-free medium during a 60-min incubation at 37 °C. Values in a-c are means ± s.e.m. *P < 0.05; **P < 0.01; ***P < 0.001. a r t i c l e s expression of the Cyp11b1 gene, which encodes the steroid 11β-hydroxylase involved in the production of corticosterone 30, 32 . These data thus disclose a previously uncharacterized spatial and functional separation between Hsd3b6 and Hsd3b1 in the mouse adrenal gland.
To further confirm the local expression of Hsd3b6 in zona glomerulosa cells, we generated an antibody to Hsd3b6 and performed immunohistochemistry (Fig. 3) . Notably, almost all zona glomerulosa cells in the Cry-null adrenal gland were found to be immunoreactive to the Hsd3b6-specific antibody (Fig. 3a) . To determine whether Cyp11b2 is coexpressed with Hsd3b6, we further processed immunostained adrenal sections for in situ hybridization with a digoxigenin-labeled Cyp11b2 probe. This double-labeling analysis revealed that nearly all Hsd3b6-positive cells also expressed Cyp11b2 (Fig. 3b) . The converse was also true; almost all Cyp11b2-positive cells were Hsd3b6-immunopositive (Fig. 3b) . This high degree of colocalization of Hsd3b6 protein with the aldosterone synthase Cyp11b2 mRNA strongly suggests that the zona glomerulosaspecific Hsd3b6 isoform is involved in aldosterone production in the mouse adrenal gland.
Steroidogenic genes in Cry-null zona glomerulosa cells
As the zona glomerulosa cell population constitutes only a fraction of the total number of adrenal gland cells, assays using whole adrenal gland (Supplementary Fig. 2 ) could lead to an underestimation of Hsd3b6 expression in this tissue. Indeed, probably because of 2.0
Sts ( a r t i c l e s this reason, the presence of adrenal Hsd3b6 has been left undefined to date 27, 28 . We next carried out laser microdissection to examine in more detail the zonal expression of Hsd3b6 and Hsd3b1 in the WT adrenal gland. (Fig. 2d) . Cells in either the zona glomerulosa or the zona fasciculata (a middle layer of the adrenal cortex) were separately excised by laser microdissection; total RNA extracts from these cells were then analyzed by RT-PCR with a primer set that can amplify both Hsd3b1 and Hsd3b6 (the sequence similarity between these two genes enabled amplification of both genes with a common primer set). Subtype-specific DNA digestion revealed almost equivalent concentrations of Hsd3b1 and Hsd3b6 mRNA in the zona glomerulosa cells (Fig. 2d) , suggestive of a substantial role of Hsd3b6 in aldosterone production by WT adrenal glands. Of note, Hsd3b6 was zona glomerulosa specific, with virtually no expression in zona fasciculata cells, whereas Hsd3b1 was predominantly expressed in zona fasciculata cells (Fig. 2d) .
A similar examination of subtype-specific expression of Cyp11b genes showed that, like Hsd3b6, expression of Cyp11b2 was confined to zona glomerulosa cells ( Fig. 2d and Supplementary Table 2 ). These observations confirm the cellular purity of our laser microdissection samples and provide further evidence of the colocalization of Hsd3b6 and Cyp11b2 expression in zona glomerulosa cells. We also performed qRT-PCR analysis on zona glomerulosa cellspecific RNA preparations and confirmed that the Hsd3b6 mRNA level was drastically increased in Cry-null zona glomerulosa cells as compared to WT cells (Fig. 2e) . We did not observe such elevated expression for transcripts of other steroidogenic genes tested (Star (encoding steroidogenic acute regulatory protein), Cyp11a1, Hsd3b1, Cyp21a1, Cyp11b1 and Cyp11b2) (Fig. 2e) .
Chronically enhanced 3-HSD activity in Cry-null mice If the observed increase in the levels of Hsd3b6 mRNA is functionally relevant, it should be accompanied by increased accumulation of Hsd3b6 protein in Cry-null adrenal glands. Immunoblot analysis revealed that the amount of Hsd3b6 protein in the Cry-null adrenal gland was highly elevated at both CT0 and CT12, whereas the amount of Cyp11a1 protein remained unchanged (Fig. 4a) . Next, we assayed 3β-HSD enzymatic activity in WT and Cry-null enucleated adrenal glands (that is, the capsular portion of the glands), which consist mainly of zona glomerulosa cells. At both CT0 and CT12, we observed a marked increase of 3β-HSD activity in enucleated adrenal glands from Cry-null mice compared to WT mice, regardless of the 3β-HSD substrate used (Fig. 4b) . In contrast, 3β-HSD activity in the decapsulated portion of the adrenal gland (containing the zona fasciculata, zona reticularis and medulla) was essentially unaffected in Cry-null mice (Supplementary Fig. 6 ). These results indicate that an elevation of 3β-HSD activity accompanies the accumulation of Hsd3b6 protein observed in aldosterone-producing zona glomerulosa cells.
We next examined whether pharmacological inhibition of 3β-HSD enzymatic activity in vivo by treatment of mice with trilostane 33 leads to a reduction in the PAC in Cry-null mice. The PAC in WT mice remained nearly unchanged by trilostane treatment even at a relatively high standard dose (8 mg per kg body weight per d) (Fig. 4c) . The apparent tolerance of WT mice to trilostane treatment has 
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-/-WT a r t i c l e s been considered to result from feedback regulation by the RAAS 34 . In marked contrast, trilostane treatment was effective in suppressing the increased PAC in Cry-null mice (Fig. 4c) , in which the constitutive overproduction of aldosterone reflects its independence from normal RAAS control. These data are consistent with the idea that the highly elevated 3β-HSD activity in zona glomerulosa cells of Cry-null mice contributes to the elevated PAC of these mice.
Aldosterone-dependent hypertension in Cry-null mice
We next explored the pathological consequences of excessive aldosterone in Cry-null mice. As a finely controlled RAAS is crucial to blood pressure homeostasis, we compared blood pressure in WT and Cry-null mice (Fig. 5) . We monitored daily changes in the mean arterial blood pressure in constant darkness by radiotelemetry (Supplementary Methods). The circadian variation in blood pressure characteristic for WT mice was completely lost in Cry-null mice (Fig. 5a) . However, when averaged over 24 h, blood pressure in WT and Cry-null mice appeared similar under standard conditions (Fig. 5b) .
Because mineralocorticoid aldosterone-dependent hypertension may be influenced by dietary salt intake 23, 24 , we next examined the salt sensitivity of blood pressure in WT and mutant mice. Normally, blood pressure is resilient to variations in sodium ingestion due to homeostatic control by RAAS. Indeed, blood pressure in WT mice (n = 3) was unaffected by the switch from a normal-salt to a high-salt diet ( Fig. 5a,b; normal-salt, 100.3 ± 7.8 (s.d.) mmHg; high salt, 97.9 ± 9.4 mm Hg), associated with a marked reduction of PAC upon the high-salt loading (Supplementary Fig. 7 ). In contrast, Cry-null mice became hypertensive in a salt-dependent manner (Fig. 5a ). All mutant mice tested (n = 5) experienced a drastic increase in blood pressure within 2 d after the change to the high-salt diet ( Fig. 5b ; normal-salt, 97.2 ± 6.3 (s.d.) mmHg; high-salt, 108.8 ± 7.9 mm Hg; P < 0.001, paired t test). The PAC of these mice remained relatively high even after the high-salt loading (Supplementary Fig. 7) . The excess of circulating aldosterone indeed contributed to the elevation of blood pressure, as the high-salt-induced hypertension in Cry-null mice (n = 3) could be reversed by treatment with eplerenone, a selective aldosterone blocker 35 (Fig. 5a,b; before eplerenone, 106.7 ± 5.5 (s.d.) mmHg; after eplerenone, 99.6 ± 5.3 mm Hg; P < 0.001, paired t test). The observed decrease in blood pressure was not due to salt desensitization induced by long-term high-salt ingestion, as the blood pressure in Cry-null mice remained elevated while they were fed the high-salt diet (Fig. 5a,b) . These data provide evidence for an aldosterone-dependent alteration of blood pressure homeostasis in Cry-null mice.
Human HSD3B1 is a functional counterpart of mouse Hsd3b6
To begin to address the question of whether these findings have relevance for human idiopathic hypertensive disease 23, 24 , we tested whether the human adrenal gland also expresses a zona glomerulosaspecific HSD3B isoform. Nontumorous adrenal tissue from adrenalectomy specimens were obtained from two human subjects (2237N and 1774N) after written informed consent. cDNA cloning from zona glomerulosa cells and subsequent DNA sequencing analysis showed that the human HSD3B1 gene, which has been considered a candidate human counterpart of the mouse Hsd3b6 gene 27, 28, 36 (Supplementary  Table 3 ) was expressed in the human adrenal zona glomerulosa samples tested (Fig. 6a-d) .
Strikingly, human HSD3B1 and HSD3B2 show a high sequence similarity (93.6% identity, including the 5′ and 3′ untranslated regions; Fig. 6a) . We thus developed subtype-specific Taqman minor groove binder (MGB) probes to allow us to distinguish these genes on the basis of nucleotide differences in the region encoding the dehydrogenase catalytic YXXXK motif 27 (where X is any amino acid): the third residue of the motif encodes histidine in HSD3B1 and tyrosine in HSD3B2 (Fig. 6a) . Cry1 
a r t i c l e s
Subtype-specific Taqman qRT-PCR analysis revealed that expression of human HSD3B1 was considerably enriched in zona glomerulosa cells, as compared to zona fasciculata cells. Conversely, expression of human HSD3B2 was predominantly expressed in zona fasciculata cells, suggesting that this gene is a counterpart of the mouse Hsd3b1 gene (Fig. 6e) . These observations support the notion that human HSD3B1, but not HSD3B2, represents a functional counterpart of the mouse Hsd3b6 gene (Supplementary Table 3) .
DISCUSSION
This study unveils a new aspect of circadian clock-related pathology: salt-sensitive hypertension. Cry-null mice show an adrenal disorder characterized by chronic overproduction of aldosterone that persists even in the reduced plasma renin activity. Our search for the pathogenic factor underlying this adrenal disorder led to the identification of Hsd3b6, which to our knowledge has not been previously associated with hypertension in rodents. The circadian clock governs the levels of daily expression of Hsd3b6. The impediment of the circadian clock could therefore be coupled to the development of hypertension through the abnormal regulation of Hsd3b6-dependent aldosterone synthesis in the adrenal gland. How do our findings relate to human aldosterone-dependent hypertensive disease? Chronic overproduction of aldosterone by human adrenal zona glomerulosa cells, a disorder referred to as primary hyperaldosteronism, is clinically known to constitute a frequent form of secondary hypertension 23 . Primary hyperaldosteronism can be classified into two distinct diagnostic categories: aldosteroneproducing adenoma and bilateral idiopathic hyperaldosteronism. Unlike aldosterone-producing adenoma, which has a known etiology that can be corrected by surgery, the pathophysiology underlying nontumorigenic idiopathic hyperaldosteronism remains totally unknown 24 , as reflected in its being labeled 'idiopathic' . Idiopathic hyperaldosteronism does not allow for surgical correction by adrenalectomy because of its bilateral nature, and specific therapies to reduce aldosterone production are not available 23 . Despite the medical importance of this disorder, the underlying mechanisms have remained unexplored largely because of the lack of a suitable animal model.
Cry-null mice, in which circulating aldosterone is chronically overproduced by the adrenal glands, represent a promising animal model of idiopathic hyperaldosteronism. Our analysis of steroidogenic gene expression in Cry-null zona glomerulosa cells led to an unexpected finding. Whereas the rate-limiting step for aldosterone production by zona glomerulosa cells remains to be experimentally defined, previous studies suggested a key role for Cyp11b2, as the enhancement of aldosterone biosynthesis by angiotensin II is associated with an acute induction of Cyp11b2 expression in zona glomerulosa cells 37 . However, we observed that Cyp11b2 expression was essentially unimpaired in Cry-null mice, suggesting another molecular mechanism for aldosterone overproduction in Cry-null mice. We thus carried out a nonbiased examination of adrenal steroidogenic genes, which led to the identification of Hsd3b6 as a new gene exclusively expressed in zona glomerulosa cells. Notably, the only effect on gene expression that we were able to detect in Cry-null adrenal glands was increased expression of zona glomerulosaspecific Hsd3b6; the expression of other steroidogenic genes tested was unaffected. Furthermore, elevation of Hsd3b6 protein abundance resulted in chronically enhanced 3β-HSD activity in Cry-null adrenal zona glomerulosa cells, and in vivo inhibition of 3β-HSD activity by trilostane was effective in suppressing the increased PAC in Cry-null mice. These data thus characterize mouse Hsd3b6 as a latent risk factor for hyperaldosteronism: chronic elevation of its activity in zona glomerulosa cells instigates an abnormal elevation of PAC.
It may be somewhat unexpected that zona glomerulosa-specific HSD3B gene expression by human HSD3B1 and mouse Hsd3b6 has escaped notice thus far. However, it should be noted that to show that human HSD3B1 gene expression is specific to zona glomerulosa cells, we had to develop a Taqman MGB probe-based qPCR method that can distinguish between transcripts of the HSD3B1 and HSD3B2 genes. Notably, these two isoforms are indistinguishable by conventional probe hybridization methods because of their extremely high DNA sequence similarity. Furthermore, as the zona glomerulosa cell population constitutes only a fraction of the total number of adrenal gland cells, the levels of gene expression in this cell type might have been underestimated in assays using whole adrenal extracts 38, 39 . Indeed, we observed that the expression of mouse Hsd3b6 was apparently low when analyzed in whole adrenal RNA. By applying lasermicrodissection technology, in combination with subtype-specific qRT-PCR, we were able to identify the zona glomerulosa-specific HSD3B genes in both human and mouse adrenal glands.
On the basis of these results, the potential involvement of the human HSD3B1 gene in adrenal zona glomerulosa pathophysiology merits further investigation. Whereas numerous studies link mutations in human HSD3B2 to 3β-HSD deficiency leading to impaired steroidogenesis in both the adrenal glands and the gonads 40, 41 , no human HSD3B1 gene mutations have been observed in clinical screening of human postnatal disorders 27 . Human HSD3B1 is expressed not only in the adrenal zona glomerulosa but also in the placenta, where HSD3B1 functions as the major 3β-HSD isoform for production of progesterone, which is vital for the maintenance of human pregnancy. It has therefore been suggested that, in a fetus homozygous for a HSD3B1 gene defect, absence of the placental enzyme would lead to interruption of pregnancy before the end of the first trimester 27, 42 .
It is therefore unclear whether decreased expression or function of human HSD3B1 might have pathological effects in the adult. Another important question is whether its increased expression or function might be associated with adult hyperaldosteronism. Although further clinical investigation will be needed to address this question, the identification of a zona glomerulosa-specific HSD3B gene subtype suggests a potential therapeutic application of subtype-specific HSD3B inhibitors. Historically, individuals with idiopathic hyperaldosteronism have been treated with a broad-spectrum HSD3B inhibitor that has negative side effects owing to its inhibition not only of aldosterone production but also of corticosterone synthesis 43, 44 . It is thus tempting to speculate that selective inhibitors for the zona glomerulosa-specific HSD3B subtype may offer new therapeutic treatments for aldosterone control.
In conclusion, we have found an adrenalopathy in circadian clockdeficient Cry-null mice. The inactivation of Cry genes leads to chronically enhanced mineralocorticoid production, which, in turn, renders blood pressure salt-sensitive. Our analysis of the hyperaldosteronemia of these mice led to the discovery of a zona glomerulosa-specific HSD3B subtype. Although it is still not known how overproduced aldosterone causes salt-sensitive hypertension in Cry-null mice, our studies implicating this HSD3B isoform in hypertension may help unravel the etiologies of salt-sensitive hypertension and idiopathic hyperaldosteronism in humans. 
METHODS
Methods
ONLINE METHODS
Mouse experiments. The generation and breeding of Cry-null mice has been described previously 14, 16, 45 . Before experiments, we housed both WT and Cry-null mice for at least 2 weeks in a 12-h light-dark cycle to synchronize (entrain) the circadian clock of WT mice to the ambient light-dark cycle. We conducted all mouse experiments in constant darkness to eliminate a potential influence of external light on steroidogenesis 21 and to unequivocally define the effects of the internal biological clock. To eliminate gender-and age-related variations, we routinely used 12-to 16-week-old male mice. We transferred the mice into constant darkness, and at selected time points on the first day in constant darkness, we killed the mice to collect plasma and tissues. For pharmacological inhibition of 3β-HSD activity, we gave the mice a daily dose of 1.6 or 8.0 mg per kg body weight trilostane (a generous gift from Mochida Pharmaceutical), administered at 6-7 h after light onset by gavage as a suspension in 1% gum tragacanth. Seven days after the start of medication, we transferred the mice into constant darkness and collected plasma at CT0 in the dark. For salt-loading tests, we fed mice with one of the following diets (CREA Japan Inc.): a normal-salt diet containing 0.2% elemental Na + , a high-salt diet containing 3.15% elemental Na + and a high-salt diet with the addition of eplerenone (a generous gift from Pfizer) at a concentration of 1.0 mg per g body weight in chow (estimated intake, 100 mg per kg body weight per d). All of the studies were approved by the Animal Experimentation Committee of Kyoto University.
Adrenal slice culture. Immediately after surgical isolation, we freed adrenal glands (one per assay) of adherent fat and cut them into four slices (about 0.4 mm thick) with fine scissors. We placed these four fresh slices in 1 ml of serum-free DMEM/F12 medium (Invitrogen), aerated with 5% CO 2 , 95% O 2 at 37 °C. To wash out the serum carryover in the tissue slices, we preincubated them for 60 min at 37 °C under a 5% CO 2 , 95% O 2 gas mixture shaking continuously at a rate of 150 cycles per minute. We replaced the preincubation medium with 1 ml of fresh serum-free medium and incubated the slices for 60 min under the same culturing conditions. We determined the amounts of aldosterone secreted into the medium by radioimmunoassay (Coat-A-Count Aldosterone kit, Siemens International).
Biochemical analysis of 3-hydroxysteroid dehydrogenase-isomerase activity.
We mechanically separated the adrenal glands into capsular and decapsulated portions according to the conventional method 29 . We determined 3β-HSD enzymatic activities in each portion as previously described 46 . We measured the conversion of H]-pregnenolone (PerkinElmer) to 3 H-progesterone and the conversion of [1, 2, 6, H]-dehydroepiandrosterone (PerkinElmer) to 3 H-androstenedione. Briefly, we incubated cell extracts containing 5 µg of protein in reaction buffer (10 mM phosphate, pH 7.5, 140 mM NaCl, 4% propylene glycol) containing either 100 nM [ 3 H]-pregnenolone plus 10 µM pregnenolone or
